SE402916B - Sett att framstella nya alfa-sulfobensylpenicillindiaminsalter - Google Patents

Sett att framstella nya alfa-sulfobensylpenicillindiaminsalter

Info

Publication number
SE402916B
SE402916B SE7309138A SE7309138A SE402916B SE 402916 B SE402916 B SE 402916B SE 7309138 A SE7309138 A SE 7309138A SE 7309138 A SE7309138 A SE 7309138A SE 402916 B SE402916 B SE 402916B
Authority
SE
Sweden
Prior art keywords
sulphobenzylpenicillindiamin
salts
methods
preparing new
alfa
Prior art date
Application number
SE7309138A
Other languages
English (en)
Swedish (sv)
Inventor
H Okada
H Fujisawa
M Fujita
T Shimamoto
H Nomura
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE402916B publication Critical patent/SE402916B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
SE7309138A 1972-07-01 1973-06-28 Sett att framstella nya alfa-sulfobensylpenicillindiaminsalter SE402916B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (xx) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
SE402916B true SE402916B (sv) 1978-07-24

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7309138A SE402916B (sv) 1972-07-01 1973-06-28 Sett att framstella nya alfa-sulfobensylpenicillindiaminsalter

Country Status (15)

Country Link
US (1) US3925357A (xx)
JP (1) JPS5512435B2 (xx)
AT (1) AT325206B (xx)
AU (1) AU469986B2 (xx)
BE (1) BE801588A (xx)
CA (1) CA996548A (xx)
CH (1) CH573435A5 (xx)
CS (1) CS168036B2 (xx)
DE (1) DE2332840A1 (xx)
FR (1) FR2190414B1 (xx)
GB (1) GB1386566A (xx)
HU (1) HU166029B (xx)
NL (1) NL7308048A (xx)
PL (1) PL92969B1 (xx)
SE (1) SE402916B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (xx) * 1978-07-29 1980-02-13
NZ528216A (en) * 2001-02-24 2006-12-22 Boehringer Ingelheim Pharma Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EA030606B1 (ru) 2006-05-04 2018-08-31 Бёрингер Ингельхайм Интернациональ Гмбх Способы приготовления лекарственного средства, содержащего полиморфы
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
KR101610005B1 (ko) * 2007-08-17 2016-04-08 베링거 인겔하임 인터내셔날 게엠베하 Fab 관련 질환의 치료에 사용하기 위한 푸린 유도체
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
EA031225B1 (ru) * 2008-08-15 2018-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Ингибиторы дпп-4 для заживления ран
EP2344195A2 (en) 2008-09-10 2011-07-20 Boehringer Ingelheim International GmbH Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
BRPI0923121A2 (pt) 2008-12-23 2015-08-11 Boehringer Ingelheim Int Formas salinas de compostos orgânico
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
ES2760917T3 (es) 2009-11-27 2020-05-18 Boehringer Ingelheim Int Tratamiento de pacientes diabéticos genotipificados con inhibidores DPP-IV como la linagliptina
JP6034781B2 (ja) 2010-05-05 2016-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 併用療法
EA201991014A1 (ru) 2010-06-24 2019-09-30 Бёрингер Ингельхайм Интернациональ Гмбх Лечение диабета
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
MX366629B (es) 2011-07-15 2019-07-17 Boehringer Ingelheim Int Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas.
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
JP2019517542A (ja) 2016-06-10 2019-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング リナグリプチンおよびメトホルミンの組合せ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (xx) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
HU166029B (xx) 1974-12-28
FR2190414B1 (xx) 1976-07-02
CH573435A5 (xx) 1976-03-15
BE801588A (fr) 1973-12-28
JPS4925121A (xx) 1974-03-06
JPS5512435B2 (xx) 1980-04-02
AU469986B2 (en) 1976-02-26
PL92969B1 (xx) 1977-04-30
CA996548A (en) 1976-09-07
AU5760073A (en) 1975-01-09
CS168036B2 (xx) 1976-05-28
FR2190414A1 (xx) 1974-02-01
GB1386566A (en) 1975-03-12
NL7308048A (xx) 1974-01-03
DE2332840A1 (de) 1974-01-17
AT325206B (de) 1975-10-10
US3925357A (en) 1975-12-09

Similar Documents

Publication Publication Date Title
SE402916B (sv) Sett att framstella nya alfa-sulfobensylpenicillindiaminsalter
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE382059B (sv) Forfarande for framstellning av nya substituerade piperidinderivat
NO149176C (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
IT1001432B (it) Procedimento per produrre n fosfonometilglicina
SE421615B (sv) Sett att framstella nya tiazolderivat
SE400771B (sv) Forfarande for framstellning av 3alfa-hydroxi- och 3alfa-hydroxi-19-norpregnaner
SE386445B (sv) Forfaranden for framstellning av nya bensotiadiazoler
SE413246B (sv) Forfarande for framstellning av kolesteroloxidas
SE411349B (sv) Sett att framstella nya penicilliner
SE419339B (sv) Forfarande for framstellning av substituerade sulfonylacetamidocefalosporiner
SE397830B (sv) Sett att framstella nya bensodioxol-piperazinderivat
SE384853B (sv) Forfarande for framstellning av nya aminer
NO139124C (no) Fremgangsmaate for fremstilling av estere
SE398880B (sv) Sett att framstella basiskt substituerade 3-bensoyl-bensofuranderivat
SE397976B (sv) Nya kinoxalin-di-n-oxider med tillvextbefordrande verkan
SE423540B (sv) Forfarande for framstellning av vissa 13-tiaprostaglandiner
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE397088B (sv) Forfarande for framstellning av nya 2-propanolderivat
SE397190B (sv) Sett att framstella substituerade dibensocykloheptener
SE384510B (sv) Forfarande for framstellning av nya isoindolinpiperazinderivat
IT999554B (it) Procedimento per preparare diacetossibutano
SE384027B (sv) Forfarande for framstellning av nya alfa-alkylsulfobensylpenicilliner
SE413022B (sv) Sett att framstella nya propylendiaminderivat
SE402454B (sv) Forfarande for framstellning av 2-alkoxi-5-alkylsulfonyl-toluen